Home
>
National Drug Code (NDC)
>
Ultravate
Ultravate - 10631-103-50 - (halobetasol propionate)
Drug Information of Ultravate
| Product NDC: | 10631-103 |
| Proprietary Name: | Ultravate |
| Non Proprietary Name: | halobetasol propionate |
| Active Ingredient(s): | .5 mg/g & nbsp; halobetasol propionate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ultravate
| Product NDC: | 10631-103 |
| Labeler Name: | Ranbaxy Laboratories Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019967 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090316 |
Package Information of Ultravate
| Package NDC: | 10631-103-50 |
| Package Description: | 50 g in 1 TUBE (10631-103-50) |
NDC Information of Ultravate
| NDC Code | 10631-103-50 |
| Proprietary Name | Ultravate |
| Package Description | 50 g in 1 TUBE (10631-103-50) |
| Product NDC | 10631-103 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | halobetasol propionate |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20090316 |
| Marketing Category Name | NDA |
| Labeler Name | Ranbaxy Laboratories Inc. |
| Substance Name | HALOBETASOL PROPIONATE |
| Strength Number | .5 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
